business company

advice

Essay




Diploma




Dissertation

Cardiogenic Pulmonary Edema Clinical Presentation: History, Physical Examination

  1. Komiya K, Ishii H, Murakami J, et al. Comparison of chest computed tomography features in the acute phase of cardiogenic pulmonary edema and acute respiratory distress syndrome on arrival at the emergency department.J Thorac Imaging . 2013 Sep. 28(5):322-8. [Medline].

  2. Ray P, Arthaud M, Birolleau S, et al. Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older.J Am Geriatr Soc . 2005 Apr. 53(4):643-8. [Medline].

  3. Pfisterer M, Buser P, Rickli H, et al. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.JAMA . 2009 Jan 28. 301(4):383-92. [Medline].

  4. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study.Circulation . 2002 Jul 23. 106(4):416-22. [Medline].

  5. Wang F, Wu Y, Tang L, et al. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis.Crit Care . 2012 May 6. 16(3):R74. [Medline].

  6. Al Deeb M, Barbic S, Featherstone R, Dankoff J, Barbic D. Point-of-care ultrasonography for the diagnosis of acute cardiogenic pulmonary edema in patients presenting with acute dyspnea: a systematic review and meta-analysis.Acad Emerg Med . 2014 Aug. 21(8):843-852. [Medline].

  7. Wang XT, Liu DW, Zhang HM, Chai WZ. Integrated cardiopulmonary sonography: a useful tool for assessment of acute pulmonary edema in the intensive care unit.J Ultrasound Med . 2014 Jul. 33(7):1231-9. [Medline].

  8. Rogoza K, Kosiak W. Usefulness of lung ultrasound in diagnosing causes of exacerbation in patients with chronic dyspnea.Pneumonol Alergol Pol . 2016. 84(1):38-46. [Medline].

  9. Sekiguchi H, Schenck LA, Horie R, et al. Critical care ultrasonography differentiates ARDS, pulmonary edema, and other causes in the early course of acute hypoxemic respiratory failure.Chest . 2015 Oct. 148(4):912-8. [Medline].

  10. Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.JAMA . Oct., 2005. 294(5):1625-33. [Medline].

  11. L'Her E, Duquesne F, Girou E, et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients.Intensive Care Med . 2004 May. 30(5):882-8. [Medline].

  12. Mehta S, Nava S. Mask ventilation and cardiogenic pulmonary edema: another brick in the wall.Intensive Care Med . 2005 Jun. 31(6):757-9. [Medline].

  13. Lazzeri C, Gensini GF, Picariello C, et al. Acidemia in severe acute cardiogenic pulmonary edema treated with noninvasive pressure support ventilation: a single-center experience.J Cardiovasc Med (Hagerstown) . 2015 Sep. 16(9):610-5. [Medline].

  14. Weitz G, Struck J, Zonak A, Balnus S, Perras B, Dodt C. Prehospital noninvasive pressure support ventilation for acute cardiogenic pulmonary edema.Eur J Emerg Med . 2007 Oct. 14(5):276-9. [Medline].

  15. Frontin P, Bounes V, Houze-Cerfon CH, et al. Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study.Am J Emerg Med . 2011 Sep. 29(7):775-81. [Medline].

  16. Willmore A, Dionne R, Maloney J, Ouston E, Stiell I. Effectiveness and safety of a prehospital program of continuous positive airway pressure (CPAP) in an urban setting.CJEM . 2015 Nov. 17(6):609-16. [Medline].

  17. Newby D. Efficacy of non-invasive ventilation in patients with acute cardiogenic pulmonary oedema: The 3CPO trial. Presented at the ESC meeting. Sept 2007. [Full Text].

  18. Pirracchio R, Resche Rigon M, Mebazaa A, Zannad F, Alla F, Chevret S. Continuous positive airway pressure (CPAP) may not reduce short-term mortality in cardiogenic pulmonary edema: a propensity-based analysis.J Card Fail . 2013 Feb. 19(2):108-16. [Medline].

  19. Mehta S, Jay GD, Woolard RH. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema.Crit Care Med . 1997 Apr. 25(4):620-8. [Medline].

  20. The Best Essay Writing Service - EssayBox.org

    Bauer JB, Randazzo MA. Nesiritide for outpatient treatment of heart failure.Am J Health Syst Pharm . 2005 Dec 15. 62(24):2639-42.

  21. Cheng JW, Merl MY, Nguyen HM. Effect of nesiritide on renal function: a retrospective review.Curr Med Res Opin . 2005 Nov. 21(11):1857-63. [Medline].

  22. Scroggins N, Edwards M, Delgado R 3rd. Increased cost effectiveness with nesiritide vs. milrinone or dobutamine in the treatment of acute decompensated heart failure.Congest Heart Fail . 2005 Nov-Dec. 11(6):311-4. [Medline].

  23. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.JAMA . 2005 Apr 20. 293(15):1900-5. [Medline].

  24. O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure.N Engl J Med . 2011 Jul 7. 365(1):32-43. [Medline].

  25. Maggioni AP, Latini R, Carson PE, e al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).Am Heart J . 2005 Mar. 149(3):548-57. [Medline].

  26. Ducharme A, Swedberg K, Pfeffer MA, et al. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.Am Heart J . Jul, 2006. 152(1):86-92. [Medline].

  27. Felker GM, Benza RL, Chandler AB, et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.J Am Coll Cardiol . 2003 Mar 19. 41(6):997-1003. [Medline].

  28. Earl GL, Fitzpatrick JT. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.Ann Pharmacother . 2005 Nov. 39(11):1888-96. [Medline].

  29. Follath F, Franco F, Cardoso JS. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.Am J Cardiol . 2005 Sep 19. 96(6A):80G-5G. [Medline].

  30. Parissis JT, Filippatos G, Farmakis D, Adamopoulos S, Paraskevaidis I, Kremastinos D. Levosimendan for the treatment of acute heart failure syndromes.Expert Opin Pharmacother . 2005 Dec. 6(15):2741-51. [Medline].

  31. Mebazaa A, Nieminen MS, Packer M, et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.JAMA . 2007 May 2. 297(17):1883-91. [Medline].

  32. Gheorghiade M, Konstam MA, Burnett JC Jr, et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.JAMA . 2007 Mar 28. 297(12):1332-43. [Medline].

  33. Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.JAMA . 2007 Mar 28. 297(12):1319-31. [Medline].

  34. Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.J Am Coll Cardiol . 2007 Feb 13. 49(6):675-83. [Medline].

  35. Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome.N Engl J Med . 2012 Dec 13. 367(24):2296-304. [Medline].

  36. Cortellaro F, Ceriani E, Spinelli M, et al. Lung ultrasound for monitoring cardiogenic pulmonary edema.Intern Emerg Med . 2016 Jul 29. [Medline].

  37. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.Am J Kidney Dis . 2003 Mar. 41(3):571-9. [Medline].

  38. Chioncel O, Ambrosy AP, Bubenek S, et al. Epidemiology, pathophysiology, and in-hospital management of pulmonary edema: data from the Romanian Acute Heart Failure Syndromes registry.J Cardiovasc Med (Hagerstown) . 2016 Feb. 17(2):92-104. [Medline].

  39. Brusasco C, Corradi F, De Ferrari A, Ball L, Kacmarek RM, Pelosi P. CPAP devices for emergency prehospital use: a bench study.Respir Care . 2015 Dec. 60(12):1777-85. [Medline].


Category: Report

Similar articles: